On August 10, 2026, the U.S. Department of Health and Human Services announced a proposed rule that would fundamentally reshape how food manufacturers introduce new ingredients into the U.S. food supply. The proposal would replace the voluntary Generally Recognized as Safe (GRAS) notification framework that has been in place since 1997 with a mandatory pre-market notification system, requiring manufacturers to notify the Food and Drug Administration before marketing any ingredient they have self-determined to be GRAS.
For nearly three decades, manufacturers have had discretion over whether to inform the FDA of their GRAS conclusions. Under the current framework, a company could conduct its own safety evaluation, rely on qualified expert consensus, and lawfully introduce an ingredient into commerce without ever engaging the agency. HHS's proposal signals a departure from that model, moving GRAS oversight closer to a pre-market compliance regime and materially altering the regulatory posture surrounding new ingredient launches.
The practical implications for food manufacturers are significant. Companies should anticipate longer product development timelines, expanded documentation obligations, and heightened scrutiny of the scientific record underlying each GRAS conclusion. Ingredients already in the market under prior self-determinations may also warrant fresh review, as the transition to a mandatory framework is likely to invite closer examination of legacy safety files, expert panel conclusions, and supporting technical data.
Stakeholders will have a defined opportunity to influence the final rule. HHS has indicated that the public comment period will remain open for 120 days following publication in the Federal Register. This window offers food manufacturers, trade associations, ingredient suppliers, and other interested parties a meaningful forum to raise concerns regarding scope, implementation timelines, transition provisions, and the evidentiary standards that will govern mandatory notifications.
Manufacturers are well advised to act now. Prudent early steps include auditing existing GRAS self-determinations, verifying the completeness of underlying safety documentation, mapping ingredient portfolios against likely notification obligations, and developing a comment strategy tailored to the company's product pipeline and risk profile. Early preparation will help mitigate compliance risk and position stakeholders to shape the contours of the final rule.
This update is provided for general informational purposes only. Clients facing specific questions about GRAS compliance or the proposed rule should seek tailored legal advice.